Teradyne stock drops more than 4% after institutional selling and breach of key moving averages

Traders Union
All News
Stocks
Teradyne slides 4.15% today

Highlights

Teradyne reported a 103.9% year-over-year revenue increase for the third quarter and maintains focus on automated test equipment and advanced robotics.
The company announced a $300 million strategic technology collaboration and investment in FormFactor, expanding its scope in technology development.
Shares of Teradyne fell 4.15% to $365.11, trading below short- and medium-term averages with indicators showing oversold conditions and a forecasted range of $339.55 to $391.66 over five days.

Stake reduction contrasts with revenue surge amid sustained downside pressure

Krilogy Financial LLC reduced its stake in Teradyne by 8.1% during the third quarter. The company reported a year-over-year revenue increase of 103.9% for the same period. Teradyne will release its third quarter 2026 financial results on October 27, 2026, following announcements of a $300 million strategic technology collaboration and investment in FormFactor. The company also continued its operations in automated test equipment and advanced robotics, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees Teradyne locked in a fragile spot after a notable stake reduction from Krilogy Financial LLC. He notes the stock losing technical support at short-term moving averages while institutional sentiment turns defensive. Weakness in the ADX and broad selling pressure undermine the impact of recent business deals. Downside gaps and oversold readings highlight trader uncertainty and risk of further declines. "Despite the occasional momentum rebound, I see elevated risk here until sellers are absorbed and institutional flows stabilize," Kharitonov says.

Viktoras Karapetjanc, expert at Traders Union, believes Teradyne’s fundamentals signal resilience despite near-term volatility. He points to the 103.9% revenue jump and major technology investments as sound drivers of long-term growth. Karapetjanc argues that strategic partnerships reinforce demand prospects, supporting the case for an eventual recovery. He emphasizes that the bullish technical framework above the 200-day moving average remains intact. "These developments signal the market offers multiple setup opportunities — I expect further growth as optimism returns," Karapetjanc notes.

Jainam Mehta, market strategist, views Teradyne as caught between short-term pressure and broader positive structure. He notes the pronounced intraday volatility and oversold momentum conditions. Mehta sees a tactical case for contrarian entries if the price stabilizes above $362.58. "A potential rebound is possible if current oversold signals translate into buying, but risk controls remain essential," he says.

Near-term weakness prevails as mixed momentum meets support above 200-day

Teradyne is trading below its 20-day and 50-day moving averages ($397.29 and $383.57), but remains above the 200-day ($342.55), reflecting short-term and medium-term pressure from sellers while maintaining a longer-term bullish alignment. The Ichimoku Kijun ($389.12) acts as overhead resistance, with the near-term ceiling at $380.9 and floor at $362.58 defining the immediate range. Momentum readings present a mixed picture: the MACD signals strong buy, but the Average Directional Index (ADX) at 11.32 is neutral and indicates a weak trend. The Relative Strength Index (RSI) is at 45.77 with a sell bias, Commodity Channel Index (CCI) shows a sell signal, and Stochastic RSI registers 0, highlighting oversold conditions. Bull/Bear Power (BBP) at -19.24 confirms sellers dominate intraday, with a forecast of an oversold market. The current price is $365.11, down $15.79 or 4.15% from the previous close, after opening with a downside gap of about $10.67 (2.8%). The price sits near the day's low, intraday volatility stands at 5.05%, and there is clear pressure after the open. Some momentum indicators point to a rebound. Sellers have dominated early action.

Earlier, analysts noted that Teradyne’s ongoing innovations in automation and chip testing were overshadowed by continued selling pressure on the stock. The current analysis extends this assessment by highlighting sustained downside momentum, with attention now shifting to the $362.58 floor as a critical threshold for further risk in the coming days.

Source of Data: TER Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.